Ryvu Therapeutics
Kraków, Poland· Est.
Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision oncology.
Private Company
Total funding raised: $95M
About
Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision oncology.
Small Molecules
Funding History
3Total raised:$95M
IPO$50M
Series B$30M
Series A$15M